Sanofi | SNY - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.63B 54M 2026-06
Amgen USD 1.58B 354M 2026-03
AstraZeneca USD 5.8B 735M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Canopy Growth CAD 31.17M 2.27M 2026-03
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Drreddys Laboratories INR 14.47B 12.45B 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Genmab DKK 208M 60M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
Glaxosmithkline GBP 2.12B 1.44B 2026-03
J&J USD 6.42B 381M 2026-06
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Merck USD 2.67B 180M 2026-03
Novartis USD 3.24B 101M 2026-06
Novartis USD 3.14B 296M 2026-03
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 267.3M 11.4M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Sanofi EUR 2.49B 252M 2026-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
UCB EUR 1.47B 193M 2025-12
Zoetis USD 588M 31M 2026-03